Institutional Ownership Lyra Therapeutics, Inc. (LYRA)
This table provides information about the institutional ownership of Lyra Therapeutics, Inc. (LYRA). We have compiled data on the 57 institutions that hold shares in the stock, with a total of 25 Million shares, which have been reported (via 13F filing form) to have a value of $221 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
12,757,562
shares
|
$113 Million
0.07% of portfolio
|
Q2 2023
Added 39.48%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,829,978
shares
|
$25 Million
0.0% of portfolio
|
Q2 2024
Added 1762.82%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
1,765,585
shares
|
$15.6 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.22%
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
May 15, 2025 Q1 2025 |
1,390,130
shares
|
$12.3 Million
0.08% of portfolio
|
Q1 2025
Reduced 29.28%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
1,058,148
shares
|
$9.36 Million
0.02% of portfolio
|
Q4 2024
Added 0.12%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,016,004
shares
|
$8.99 Million
0.0% of portfolio
|
Q1 2025
Added 14.68%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
May 15, 2025 Q1 2025 |
533,200
shares
|
$4.72 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
488,720
shares
|
$4.33 Million
0.0% of portfolio
|
Q3 2024
Added 88.1%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
434,226
shares
|
$3.84 Million
0.0% of portfolio
|
Q1 2025
Added 2.18%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
370,194
shares
|
$3.28 Million
0.0% of portfolio
|
Q1 2025
Reduced 33.36%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
364,478
shares
|
$3.23 Million
0.0% of portfolio
|
Q1 2025
Reduced 5.45%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
332,639
shares
|
$2.94 Million
0.0% of portfolio
|
Q1 2025
Added 16.18%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
233,989
shares
|
$2.07 Million
0.0% of portfolio
|
Q4 2024
Added 0.57%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
217,567
shares
|
$1.93 Million
0.0% of portfolio
|
Q1 2025
Added 110.35%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
193,145
shares
|
$1.71 Million
0.0% of portfolio
|
Q1 2025
Reduced 8.02%
|
|
|
New York State Common Retirement Fund
|
May 01, 2025 Q1 2025 |
154,800
shares
|
$1.37 Million
0.0% of portfolio
|
Q3 2024
Reduced 59.57%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
111,609
shares
|
$987,739
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
87,710
shares
|
$776,233
0.0% of portfolio
|
Q4 2024
Reduced 52.96%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
65,619
shares
|
$580,728
0.0% of portfolio
|
Q1 2025
Reduced 69.69%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
58,041
shares
|
$513,662
0.0% of portfolio
|
Q1 2025
Added 102.14%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
56,277
shares
|
$498,051
0.0% of portfolio
|
Q1 2025
Reduced 64.03%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2025 Q1 2025 |
52,736
shares
|
$466,713
0.0% of portfolio
|
Q1 2025
Added 32.55%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
50,038
shares
|
$442,836
0.0% of portfolio
|
Q1 2025
Reduced 33.51%
|
|
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
43,997
shares
|
$389,373
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
35,177
shares
|
$311,316
0.0% of portfolio
|
Q1 2025
Reduced 7.68%
|